volume 10, issue 1, P417-423 2021
DOI: 10.21037/tcr-20-2545
View full text
|
|
Share

Abstract: Background: Radiotherapy has long been considered the standard adjuvant treatment after radical orchidectomy for stage I seminoma. However, active surveillance and carboplatin chemotherapy have recently become alternative strategies. Despite this, the transition in management regimens is not yet fully recognized. Thus, this study aimed to analyze the 40-year trend in radiotherapy for patients with stage I seminoma in the United States.Methods: We identified 21,976 men in the Surveillance, Epidemiology, and End…

expand abstract